Co-treatment With Pegvisomant and a Somatostatin Analogue (SA) in SA-responsive Acromegalic Patients

NCT00652379 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Acromegaly
Insulin Resistance
Impaired Glucose Tolerance

Interventions

DRUG: Pegvisomant
DRUG: Somatostatin analog (lanreotide or octreotide)

Sponsor

University of Aarhus

Collaborators

[object Object]
[object Object]
[object Object]